The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126183441 12618344 1 I 20150319 20160720 20160803 20160803 EXP IT-ACTAVIS-2016-16682 ACTAVIS 77.50 YR M Y 69.00000 KG 20160803 CN IT IT

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126183441 12618344 1 PS Irinotecan IRINOTECAN 1 Intravenous (not otherwise specified) 320 MG, CYCLICAL UNKNOWN 78589 320 MG CONCENTRATE FOR SOLUTION FOR INFUSION
126183441 12618344 2 SS FLUOROURACIL. FLUOROURACIL 1 Intravenous (not otherwise specified) 4320 MG, CYCLICAL UNKNOWN 0 4320 MG SOLUTION FOR INFUSION
126183441 12618344 3 SS AVASTIN BEVACIZUMAB 1 Intravenous (not otherwise specified) 340 MG, CYCLICAL UNKNOWN 0 340 MG SOLUTION FOR INFUSION
126183441 12618344 4 C ACEQUIDE 2 UNK UNKNOWN 0
126183441 12618344 5 C LEDERFOLIN LEUCOVORIN CALCIUM 1 Intravenous (not otherwise specified) 360 MG, DAILY 52198 MG UNKNOWN 0 360 MG SOLUTION FOR INFUSION QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126183441 12618344 1 Rectal adenocarcinoma
126183441 12618344 2 Rectal adenocarcinoma
126183441 12618344 3 Rectal adenocarcinoma
126183441 12618344 4 Product used for unknown indication
126183441 12618344 5 Rectal adenocarcinoma

Outcome of event

Event ID CASEID OUTC COD
126183441 12618344 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126183441 12618344 Abdominal pain
126183441 12618344 Muscle spasms
126183441 12618344 Neutropenia
126183441 12618344 Thrombocytopenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126183441 12618344 1 20150210 0
126183441 12618344 2 20150210 0
126183441 12618344 3 20150210 0
126183441 12618344 5 20150210 20150728 0